Clinical Trial Update: Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation [Phase 1]

View source ↗

Summary

Phase 1 trial assessing immunologic effects of supplemental monosaccharide and nucleoside derivatives in patients with PGM3-related disorders; the study has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Disorder of Glycosylation
• Phosphoglucomutase 3 Deficiency

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: PGM3 | Phase 1 | Status: TERMINATED